Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to find the highest safe dose of the drug
Bevacizumab that can be given in combination with chemoradiation for the treatment of
pancreatic cancer. The effect that this combination treatment has on the tumor will also be
studied.